Crystagen 20 mg
A short peptide discussed in aging spleen-culture research.
CAD $67.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0044 Listed amount per vial: 20 mg Sales unit: 1 vial
Read the research in context.
A short peptide discussed in aging spleen-culture research.
- Age-Related Molecular Aspects of Immunomodulating Activity of Peptides in the Spleen — source
- Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: The named primary culture paper and the patent sequence are separate records; neither establishes the identity of this supplier’s vial. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for Crystagen, product reference MRD-0044.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 20 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.